Lung Calcification in Dogs (Pulmonary Calcinosis)
- Occurrence: very rare
- Location of disease: Chest
When to visit the vet?
Non-urgent see a veterinarian within 2–3 days
If the condition worsens / symptoms persist, consult a veterinarian.
The most important facts at a glance
Pulmonary calcinosis in dogs is a condition in which calcium salts accumulate in the lung tissue, which can lead to breathing problems. This calcification can develop through two main mechanisms: dystrophic, when damaged tissue attracts calcium, or metastatic, when a high blood calcium level leads to deposits in healthy tissue. A common cause is hypercalcemia, which can be triggered by hormonal or metabolic disorders such as hyperparathyroidism, vitamin D overdose, or certain cancers. Kidney disease and toxic reactions to substances can also promote pulmonary calcinosis.
Symptoms include Cough, increased breathing rate, and reduced exercise tolerance. The disease is usually diagnosed with X-rays, blood tests, and sometimes a lung biopsy. Treatment depends on the cause and may include normalizing calcium levels, stopping vitamin D intake, or cancer therapy. The prognosis depends on the underlying cause: while reversible causes offer a good prognosis, untreatable diseases can severely affect quality of life.
Preventive measures include a balanced diet and regular veterinary check-ups to detect early signs of metabolic disorders. Research focuses on the exact mechanisms of the disease, genetic factors, improved diagnostic methods, and new therapeutic approaches.
Causes
Pulmonary calcinosis is a pathological accumulation of calcium salts in the lung tissue. This phenomenon can be caused by both dystrophic and metastatic mechanisms. Dystrophic calcification occurs when already damaged or dead tissue attracts calcium, while metastatic calcification is the result of a systemic excess of calcium that deposits in healthy tissue.
An important aspect of pulmonary calcinosis is the ratio between calcium and phosphorus in the blood, which is often influenced by hormonal or metabolic disorders. Hypercalcemia, a condition of elevated calcium levels in the blood, is often associated with pulmonary calcinosis. This hypercalcemia can be caused by various diseases, such as hyperparathyroidism, vitamin D intoxication / poisoning, or certain cancers.
The causes of pulmonary calcinosis in dogs are varied. One of the most common causes is hypercalcemia, which can result from primary hyperparathyroidism or as a secondary response to chronic kidney disease. Toxic reactions to excessive vitamin D intake—either from supplements or from ingesting substances such as certain plants or rodenticides—can also play a role.
Cancer can also lead to pulmonary calcinosis. Tumors that produce parathyroid hormone-like substances can disrupt calcium regulation. These tumors are often part of paraneoplastic syndromes associated with lymphomas or adenocarcinomas. Chronic kidney disease can also lead to an imbalance of calcium and phosphorus, which promotes calcium deposition in the lungs.
Symptoms
Symptoms of pulmonary calcinosis can vary and depend on the severity and extent of the calcification. In the early stages, the disease may be asymptomatic, especially if the deposits are small and inconspicuous. As the disease progresses, however, clear clinical signs may develop.
A common symptom is shortness of breath, as the calcified areas of the lung lose their ability to expand and exchange gases. Dogs may also show Cough, which can be either dry or productive. In severe cases, cyanosis may occur—a bluish discoloration of the mucous membranes indicating a lack of oxygen in the blood.
Other symptoms may include general weakness, loss of appetite, and Weight loss. In some cases, Fever may also occur, especially if there is a secondary infection. Because the symptoms are nonspecific, it can be difficult to diagnose pulmonary calcinosis based on clinical signs alone.
Diagnosis
Diagnosis of pulmonary calcinosis is usually made through a combination of clinical examination, medical history, and diagnostic imaging. Chest X-rays are often the first diagnostic tool used to detect calcifications in the lungs. These appear as bright, dense areas on the images. In some cases, computed tomography (CT) may be needed to determine the exact extent of the calcification.
Blood tests are also important to identify the underlying causes of pulmonary calcinosis. Measuring blood calcium and phosphorus levels can provide clues about possible metabolic disorders. An elevated calcium level may indicate hypercalcemia, while an imbalance between calcium and phosphorus may point to chronic kidney disease or another underlying condition.
In addition, a lung biopsy may be required to confirm the diagnosis and rule out other diseases. A biopsy allows microscopic examination of lung tissue to assess the presence of calcium deposits and any accompanying inflammatory changes.
Therapy
Treatment of pulmonary calcinosis depends on the underlying cause. In cases of hypercalcemia, treatment aims to normalize blood calcium levels. This can be done by administering medications that reduce calcium absorption or increase calcium excretion via the kidneys.
In cases of vitamin D intoxication / poisoning, treatment usually involves immediately stopping the vitamin D source and supporting kidney function with fluid therapy and other supportive measures. When cancer is the cause, chemotherapy or radiation therapy may be needed to shrink the tumor and reduce paraneoplastic effects.
In some cases—especially when chronic kidney disease is present—long-term treatment may be necessary to slow the progression of calcification and relieve symptoms. Dietary adjustments that reduce calcium and phosphorus intake can also be helpful.
Prognosis and follow-up care
The prognosis for dogs with pulmonary calcinosis depends heavily on the underlying cause and how far the disease has progressed. If the cause can be treated successfully—for example, in reversible hypercalcemia—the prognosis is usually good.
However, if pulmonary calcinosis is due to an untreatable or progressive disease, such as some cancers or severe kidney disease, the prognosis may be worse. Early diagnosis and intervention are crucial for achieving the best outcomes.
With severe lung calcification that leads to significant Respiratory distress, the dog’s quality of life can be greatly affected, and the prognosis may be poor. In such cases, it is important to assess the animal’s quality of life and make humane decisions.
Prevention
Prevention of pulmonary calcinosis in dogs primarily involves avoiding the underlying causes whenever possible. A balanced diet that does not contain excessive amounts of vitamin D or calcium is crucial, especially for dogs prone to metabolic diseases.
Regular veterinary check-ups can help detect early signs of metabolic disorders before they lead to pulmonary calcinosis. This is especially important for older dogs or those prone to chronic illnesses.
For dogs at increased risk of cancer, regular health checks and, if appropriate, early detection programs can help prevent the development of paraneoplastic syndromes that can lead to pulmonary calcinosis.
Outlook on current research
Pulmonary calcinosis, also called lung calcification, is a condition in which calcium salts deposit in the lungs. These calcifications can impair normal lung function and lead to breathing problems. The causes of this condition are varied and can range from systemic diseases to local lung changes. Current research is intensively investigating the exact mechanisms that contribute to the development of pulmonary calcinosis, as well as new diagnostic and treatment options.
One focus of research is examining the role of metabolic diseases—especially hypercalcemia—in the development of pulmonary calcinosis. Hypercalcemia, a condition of elevated calcium levels in the blood, can be caused by various diseases, including hyperparathyroidism and certain tumors. Research is investigating how these systemic diseases lead to calcium deposition in the lungs and which molecular pathways are involved.
Another area of research looks at genetic factors that could contribute to pulmonary calcinosis. There is evidence that certain genetic predispositions increase the risk of developing this condition. Genome-wide association studies (GWAS) and other genetic analyses are used to identify specific genes and genetic variants associated with pulmonary calcinosis.
The development of new diagnostic methods is also an active area of research. Currently, pulmonary calcinosis is often diagnosed using X-rays or CT scans, but these typically only reveal advanced stages of the disease. Researchers are working on developing biomarkers that could enable earlier detection, as well as improving imaging techniques to identify and quantify calcium deposits more precisely.
In addition, new therapeutic approaches are being investigated. While treating the underlying cause of pulmonary calcinosis is often the priority, there is growing interest in developing specific therapies that directly target calcium deposits. Experimental approaches aimed at modulating calcium metabolism or promoting resorption of calcium deposits are the subject of current studies.
Overall, research into pulmonary calcinosis aims to gain a better understanding of the pathophysiology of this condition in order to develop more precise diagnostic tools and more effective treatment strategies. Interdisciplinary collaboration between veterinarians, biochemists, and geneticists plays a crucial role in this work.